You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Article Text

Article menu

Download PDFPDF

Correction
Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

http://dx.doi.org/10.1136/jitc-2023-006802corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Gaißler A, Bochem J, Spreuer J, et al. Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma. Journal for ImmunoTherapy of Cancer 2023;11:e006802. doi: 10.1136/jitc-2023-006802

    The licence was updated to CC-BY in September 2023. The funding statement has been updated to include the following "we acknowledge support from the Open Access Publishing Fund of the University of Tübingen".